Concepts (65)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| STAT3 Transcription Factor | 4 | 2018 | 90 | 1.880 |
Why?
|
| Signal Transduction | 3 | 2018 | 1908 | 0.660 |
Why?
|
| Neuregulin-1 | 1 | 2018 | 23 | 0.620 |
Why?
|
| Malaria, Cerebral | 1 | 2018 | 31 | 0.620 |
Why?
|
| Glioma | 2 | 2017 | 79 | 0.600 |
Why?
|
| Newcastle disease virus | 1 | 2017 | 1 | 0.600 |
Why?
|
| Neoplastic Stem Cells | 2 | 2017 | 78 | 0.600 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2017 | 62 | 0.570 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 269 | 0.540 |
Why?
|
| Receptors, Notch | 1 | 2014 | 33 | 0.480 |
Why?
|
| TRPM Cation Channels | 1 | 2014 | 35 | 0.480 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2013 | 14 | 0.460 |
Why?
|
| Heme | 1 | 2013 | 70 | 0.440 |
Why?
|
| Apoptosis | 3 | 2018 | 1398 | 0.410 |
Why?
|
| Interleukin-6 | 1 | 2012 | 153 | 0.400 |
Why?
|
| Cell Division | 1 | 2012 | 307 | 0.400 |
Why?
|
| Receptors, CXCR3 | 1 | 2011 | 31 | 0.400 |
Why?
|
| Chemokine CXCL10 | 1 | 2011 | 37 | 0.390 |
Why?
|
| Neoplasm Proteins | 1 | 2012 | 213 | 0.370 |
Why?
|
| Endothelial Cells | 1 | 2013 | 308 | 0.360 |
Why?
|
| Brain Neoplasms | 2 | 2017 | 111 | 0.250 |
Why?
|
| Base Sequence | 2 | 2014 | 997 | 0.200 |
Why?
|
| Promoter Regions, Genetic | 2 | 2014 | 515 | 0.200 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 1502 | 0.200 |
Why?
|
| Molecular Sequence Data | 2 | 2014 | 1568 | 0.190 |
Why?
|
| Protein Binding | 2 | 2014 | 972 | 0.190 |
Why?
|
| Cell Line, Tumor | 2 | 2017 | 2231 | 0.170 |
Why?
|
| RNA, Messenger | 2 | 2014 | 1207 | 0.170 |
Why?
|
| Hemangioendothelioma | 1 | 2018 | 2 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2014 | 807 | 0.150 |
Why?
|
| Coculture Techniques | 1 | 2018 | 101 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 1039 | 0.130 |
Why?
|
| Animals | 3 | 2018 | 15081 | 0.130 |
Why?
|
| Phosphotyrosine | 1 | 2014 | 23 | 0.120 |
Why?
|
| Epithelial Cells | 1 | 2018 | 384 | 0.120 |
Why?
|
| Retinal Dehydrogenase | 1 | 2014 | 11 | 0.120 |
Why?
|
| Subcellular Fractions | 1 | 2014 | 77 | 0.120 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 189 | 0.120 |
Why?
|
| Cells, Cultured | 1 | 2018 | 1518 | 0.120 |
Why?
|
| Isoenzymes | 1 | 2014 | 161 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 173 | 0.120 |
Why?
|
| Janus Kinases | 1 | 2013 | 21 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 251 | 0.110 |
Why?
|
| Humans | 5 | 2018 | 37093 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 1609 | 0.110 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 172 | 0.110 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 1371 | 0.110 |
Why?
|
| Tamoxifen | 1 | 2012 | 65 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2014 | 513 | 0.100 |
Why?
|
| Binding Sites | 1 | 2013 | 651 | 0.100 |
Why?
|
| Receptors, Estrogen | 1 | 2012 | 156 | 0.100 |
Why?
|
| Chemotaxis | 1 | 2011 | 60 | 0.100 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2011 | 59 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 623 | 0.090 |
Why?
|
| Cell Movement | 1 | 2014 | 571 | 0.090 |
Why?
|
| Models, Biological | 1 | 2014 | 677 | 0.090 |
Why?
|
| Estradiol | 1 | 2012 | 262 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2013 | 928 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 626 | 0.090 |
Why?
|
| Cell Line | 1 | 2013 | 1354 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 610 | 0.080 |
Why?
|
| Mice | 1 | 2018 | 5913 | 0.070 |
Why?
|
| Inflammation | 1 | 2011 | 618 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 1015 | 0.070 |
Why?
|
| Female | 1 | 2012 | 20969 | 0.030 |
Why?
|